Locust Walk Insights

LOCUST WALK INSIGHTS

Whitepaper Download: Inside Out

Based on recent acquisition activity by two of the largest pharmaceutical companies, it seems as if the historical orthodoxy that great biopharma companies are made from the inside out may be losing validity.

My (National Lampoon’s) European Vacation

I recently returned from a month in Europe as part of our effort to expand Locust Walk's European practice. It was an amazing trip meeting great people and learning valuable lessons. While I did not visit all countries for business, I thought I'd share a...

Q2 2019 Report: Global Trends in Biopharma Transactions

Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our Q2 2019 Report: Global Trends in Biopharma Transactions applies the latest data to analyze current activities in the life science deal...

Q2 2019: Global Trends in Medtech Transactions

Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our Q2 2019 Report: Global Trends in Medtech Transactions applies the latest data to analyze current activities in the life sciences deal...

Q1 2019: Global Trends in Medtech Transactions

Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our Q1 2019 Report: Global Trends in Medtech Transactions applies the latest data to analyze current activities in the life sciences deal...

Q1 2019 Report: Global Trends in Biopharma Transactions

In this report you can find an overview and analysis of the following across the biopharma market in the US, Europe, and Asia (China and Japan). Key performance indicators for the life science market​​ IPO and private financing activity and performance​​ Deal activity...

The Art of the Multi-Track Deal Whitepaper

Pursuing multiple deal options in parallel, known as a multi-track process, can create competitive tension that will enable a company to obtain the most value out of the deal, whether the result of that process is an asset sale, global or regional partnership, a new...

The Asia Factor Whitepaper

How Does a Smart Deal Maker "Play" This Region and Optimize the Capital Raising and Strategic Deal Making Opportunities? Authors: Hayato Watanabe, SVP, Head of Asia Koji Hirabata, Associate Stefanie Gan, Analyst Although their biopharma ecosystem dynamics are markedly...